Company profile for Repertoire Immune Medicines

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is founded on the premise that the repertoire of TCR-antigen codes that drive health and disease represents one of the greatest opportunities for innovation in medical ...
Repertoire Immune Medicines, a Flagship Pioneering company, is a clinical stage biotechnology company working to unleash the remarkable power of the human immune system to prevent, treat or cure cancer, autoimmune conditions and infectious diseases. The company is founded on the premise that the repertoire of TCR-antigen codes that drive health and disease represents one of the greatest opportunities for innovation in medical science. The company harnesses and deploys the intrinsic ability of T cells to prevent and cure disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
One Kendall Square, Cambridge, Massachusetts, 02139
Telephone
Telephone
(617) 949-5600
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/roches-genentech-builds-autoimmune-repertoire-deal-worth-765m

FIERCE BIOTECH
24 Apr 2025
BMS pays $65M to expand Repertoire of autoimmune assets
BMS pays $65M to expand Repertoire of autoimmune assets

30 Apr 2024

// Nick Paul Taylor FIERCE BIOTECH

https://www.fiercebiotech.com/biotech/bms-pays-65m-expand-repertoire-autoimmune-assets

Nick Paul Taylor FIERCE BIOTECH
30 Apr 2024

https://www.prnewswire.com/news-releases/repertoire-immune-medicines-and-bristol-myers-squibb-announce-multi-year-strategic-collaboration-to-develop-tolerizing-vaccines-for-autoimmune-diseases-302127861.html

PR NEWSWIRE
29 Apr 2024

https://www.businesswire.com/news/home/20221110005379/en

BUSINESSWIRE
10 Nov 2022

https://www.fiercebiotech.com/biotech/scoop-flagship-founded-repertoire-cuts-45-its-staff

Max Bayer FIERCEBIOTECH
07 Nov 2022

https://www.businesswire.com/news/home/20221106005112/en

BUSINESSWIRE
07 Nov 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty